Filing Details
- Accession Number:
- 0001209191-10-014553
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-03-04 12:00:00
- Reporting Period:
- 2010-03-03
- Filing Date:
- 2010-03-04
- Accepted Time:
- 2010-03-04 17:09:58
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1047699 | King Pharmaceuticals Inc | KG | Pharmaceutical Preparations (2834) | 541684963 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1283061 | A Brian Markison | 501 Fifth Street Bristol TN 37620 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2010-03-03 | 69,744 | $11.72 | 561,646 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $11.70 to $11.755, inclusive. Full information regarding the number of shares sold at each separate price at the range set forth in this footnote has been provided to King Pharmaceuticals, Inc. and will be provided upon request to any security holder of King Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission.
Billionaire Hedge Funds
